Hospital
HDMC Holdings, LLC
HDMC Holdings, LLC was paid $10.71M by Medicaid between Jan 2018 and Nov 2024, across 230 billing codes. Its largest line is 99283, emergency room visit (moderate) — 13% of everything it billed.
33Billing provider infoHDMC HOLDINGS, LLC
JOSHUA TREE, CA 92252
JOSHUA TREE, CA 92252
33aNPI1851787295assigned 04/13/2015
33bProvider typeGeneral Acute Care Hospital
28Total paid$10.71M
24GClaims421,877
24DCodes billed230
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#176 of 410
Median peer was paid$6.90M
This provider vs. median1.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 54,145 | $1.05M | |
| 2019 | 42,332 | $931K | |
| 2020 | 32,503 | $826K | |
| 2021 | 38,250 | $945K | |
| 2022 | 84,252 | $2.36M | |
| 2023 | 85,890 | $2.29M | |
| 2024incomplete | 84,505 | $2.32M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 13% | 30,270 | 26,254 | $1.44M |
| Z7502 | 8.7% | 24,773 | 24,314 | $935K | |
| 0450 | Emergency room services | 8.3% | 17,558 | 14,808 | $893K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 5.5% | 8,141 | 2,590 | $585K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.5% | 3,815 | 3,634 | $483K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.3% | 2,740 | 2,644 | $465K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.0% | 8,147 | 7,481 | $428K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.5% | 10,516 | 9,629 | $269K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.3% | 6,415 | 5,588 | $250K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.3% | 9,714 | 8,915 | $242K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.3% | 26,457 | 23,397 | $241K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.9% | 4,217 | 3,870 | $203K |
218 more codes
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.9% | 2,292 | $200K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.6% | 15,905 | $176K |
| 72125 | Computed tomography, cervical spine; without contrast material | 1.6% | 1,101 | $170K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1.5% | 4,376 | $165K |
| 99070 | 1.2% | 21,880 | $131K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.2% | 2,947 | $131K |
| 99499 | 1.2% | 1,730 | $129K | |
| Z7610 | 1.2% | 10,718 | $129K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.2% | 1,607 | $124K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.2% | 2,037 | $123K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.1% | 3,991 | $118K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.0% | 3,664 | $108K |
| 80053 | Comprehensive metabolic panel | <1% | 8,180 | $104K |
| 84484 | <1% | 7,299 | $104K | |
| 71250 | <1% | 588 | $92K | |
| 99285 | Emergency room visit (most serious) | <1% | 1,285 | $82K |
| 71045 | Radiologic examination, chest; single view | <1% | 9,506 | $81K |
| 97763 | <1% | 1,581 | $74K | |
| 83690 | <1% | 7,109 | $64K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 144 | $60K |
| 80076 | <1% | 5,394 | $56K | |
| 99221 | <1% | 384 | $56K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,427 | $54K |
| 72131 | <1% | 390 | $54K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 372 | $53K |
| 99284 | Emergency room visit (serious) | <1% | 1,026 | $52K |
| 81025 | <1% | 6,889 | $51K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,038 | $49K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 3,802 | $49K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 1,140 | $48K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 895 | $48K |
| 81001 | <1% | 10,540 | $44K | |
| 83605 | <1% | 2,624 | $40K | |
| 90837 | Psychotherapy session, about an hour | <1% | 609 | $39K |
| J3490 | Unclassified drugs | <1% | 6,719 | $33K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 157 | $32K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 8,310 | $31K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,556 | $31K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 428 | $30K |
| 97161 | <1% | 585 | $28K | |
| 93971 | <1% | 321 | $27K | |
| 83880 | <1% | 1,347 | $26K | |
| G0378 | Hospital observation service, per hour | <1% | 464 | $26K |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 2,590 | $25K |
| 59025 | Fetal non-stress test | <1% | 587 | $25K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 486 | $25K |
| 87040 | <1% | 1,401 | $25K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 441 | $25K |
| 87400 | <1% | 3,172 | $24K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,191 | $24K |
| 94664 | <1% | 1,711 | $22K | |
| 90715 | <1% | 622 | $21K | |
| 73630 | <1% | 888 | $19K | |
| 73130 | <1% | 839 | $19K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 4,629 | $18K |
| 73610 | <1% | 776 | $18K | |
| 82150 | <1% | 1,898 | $18K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 74 | $18K |
| 85730 | <1% | 2,558 | $18K | |
| 97750 | <1% | 262 | $17K | |
| 70486 | <1% | 115 | $16K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 7,844 | $16K |
| Z9725 | <1% | 524 | $16K | |
| 83735 | <1% | 2,037 | $16K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 261 | $16K |
| 73030 | <1% | 739 | $16K | |
| 76801 | <1% | 347 | $16K | |
| 84703 | <1% | 1,488 | $15K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 121 | $15K |
| 84702 | <1% | 903 | $14K | |
| 85610 | <1% | 2,977 | $13K | |
| 72100 | <1% | 512 | $13K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 3,130 | $13K |
| G0299 | Direct skilled nursing services of a registered nurse (rn) in the home health or hospice setting, each 15 minutes | <1% | 201 | $13K |
| 72128 | <1% | 98 | $12K | |
| 73110 | <1% | 498 | $12K | |
| 86850 | <1% | 1,214 | $11K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 785 | $11K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 6,104 | $10K |
| 82962 | <1% | 1,744 | $10K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 403 | $10K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 374 | $10K |
| 83874 | <1% | 521 | $10K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 24 | $9K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 482 | $9K |
| 85379 | <1% | 710 | $9K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,235 | $9K |
| 80061 | Lipid panel | <1% | 586 | $8K |
| 73564 | <1% | 366 | $8K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 131 | $7K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,507 | $7K |
| 87186 | <1% | 667 | $7K | |
| 86901 | <1% | 1,410 | $7K | |
| J2704 | Injection, propofol, 10 mg | <1% | 901 | $7K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,318 | $6K |
| 72141 | <1% | 12 | $6K | |
| 87070 | <1% | 491 | $6K | |
| 86900 | <1% | 1,591 | $6K | |
| 81000 | <1% | 1,019 | $5K | |
| 73562 | <1% | 261 | $5K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,145 | $5K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 76 | $5K |
| 82550 | <1% | 812 | $5K | |
| 87430 | <1% | 377 | $5K | |
| 00000 | <1% | 125 | $4K | |
| 81003 | <1% | 1,199 | $4K | |
| 87420 | <1% | 341 | $4K | |
| 96368 | <1% | 258 | $4K | |
| 72170 | <1% | 264 | $4K | |
| 73221 | <1% | 13 | $4K | |
| 76641 | <1% | 62 | $4K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 434 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 372 | $4K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 4,516 | $4K |
| 96367 | <1% | 123 | $4K | |
| 82948 | <1% | 476 | $3K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 224 | $3K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 572 | $3K |
| 76536 | <1% | 79 | $3K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 212 | $3K |
| 87077 | <1% | 553 | $3K | |
| X3908 | <1% | 92 | $3K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 53 | $3K |
| Z7506 | <1% | 77 | $3K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 1,753 | $3K |
| 12001 | <1% | 98 | $2K | |
| 0360 | <1% | 17 | $2K | |
| 84145 | <1% | 171 | $2K | |
| 0002A | <1% | 56 | $2K | |
| 88313 | <1% | 71 | $2K | |
| 0762 | <1% | 38 | $2K | |
| 73502 | <1% | 96 | $2K | |
| 73080 | <1% | 60 | $2K | |
| 97799 | <1% | 48 | $2K | |
| 73590 | <1% | 124 | $2K | |
| 76830 | Ultrasound, transvaginal | <1% | 41 | $2K |
| 0001A | <1% | 52 | $2K | |
| 86592 | <1% | 1,110 | $2K | |
| 76870 | <1% | 38 | $2K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 921 | $2K |
| 93970 | <1% | 14 | $2K | |
| 74018 | <1% | 121 | $2K | |
| 82652 | <1% | 45 | $1K | |
| 84439 | <1% | 132 | $1K | |
| 93307 | <1% | 13 | $1K | |
| 86762 | <1% | 423 | $1K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 907 | $1K |
| 87340 | <1% | 99 | $1K | |
| 93308 | <1% | 17 | $1K | |
| A4217 | Sterile water/saline, 500 ml | <1% | 79 | $1K |
| 84436 | <1% | 136 | $1K | |
| 0011A | <1% | 26 | $1K | |
| 87081 | <1% | 131 | $1K | |
| 73090 | <1% | 55 | $988.94 | |
| 77065 | Tomosynthesis, mammo | <1% | 15 | $965.40 |
| J1953 | Injection, levetiracetam, 10 mg | <1% | 14 | $953.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 262 | $915.30 |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 37 | $888.56 |
| 84100 | <1% | 232 | $882.23 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 739 | $839.18 |
| 71010 | <1% | 54 | $833.84 | |
| Z7514 | <1% | 14 | $818.58 | |
| 51702 | <1% | 26 | $812.98 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 518 | $770.04 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 18 | $728.00 |
| X4304 | <1% | 20 | $649.20 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 12 | $643.17 |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 39 | $611.97 |
| 36415 | Collection of venous blood by venipuncture | <1% | 369 | $584.49 |
| 29125 | <1% | 40 | $549.20 | |
| 77080 | <1% | 26 | $524.14 | |
| 86140 | <1% | 89 | $490.55 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 70 | $490.52 |
| 85652 | <1% | 167 | $481.19 | |
| 87899 | <1% | 33 | $474.39 | |
| 0710 | <1% | 18 | $470.34 | |
| 99000 | <1% | 122 | $442.86 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 138 | $407.54 |
| 86696 | <1% | 39 | $390.00 | |
| 83970 | <1% | 86 | $387.86 | |
| 12002 | <1% | 13 | $345.62 | |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 80 | $342.72 |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 71 | $340.19 |
| 82310 | <1% | 74 | $331.52 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 189 | $316.54 |
| 72070 | <1% | 13 | $305.44 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 160 | $293.50 |
| 86695 | <1% | 21 | $279.44 | |
| 83655 | <1% | 77 | $259.17 | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 12 | $258.18 |
| J1815 | Injection, insulin, per 5 units | <1% | 76 | $244.56 |
| 29515 | <1% | 28 | $243.17 | |
| 86803 | <1% | 14 | $226.52 | |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 96 | $224.76 |
| 10060 | <1% | 15 | $220.00 | |
| 73620 | <1% | 12 | $218.29 | |
| 86708 | <1% | 14 | $196.56 | |
| 86704 | <1% | 14 | $191.24 | |
| 73552 | <1% | 14 | $188.91 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 244 | $172.60 |
| 86706 | <1% | 14 | $170.38 | |
| 84403 | <1% | 12 | $166.72 | |
| 82274 | <1% | 12 | $137.16 | |
| 84480 | <1% | 31 | $113.77 | |
| 85651 | <1% | 27 | $96.71 | |
| 85380 | <1% | 28 | $94.50 | |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 48 | $75.50 |
| 84154 | <1% | 13 | $63.70 | |
| 84153 | <1% | 13 | $63.31 | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | <1% | 14 | $44.88 |
| A9270 | Non-covered item or service | <1% | 365 | $42.66 |
| 86038 | <1% | 15 | $42.30 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 167 | $33.77 |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 15 | $31.96 |
| J0456 | Injection, azithromycin, 500 mg | <1% | 15 | $25.76 |
| A9150 | Non-prescription drugs | <1% | 170 | $5.11 |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 0% | 3,805 | $0.00 |
| G0177 | Training and educational services related to the care and treatment of patient's disabling mental health problems per session (45 minutes or more) | 0% | 436 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFISH, JIMMY (CFO)
| Provider | Location | Paid |
|---|---|---|
| Desert Regional Medical Center, INC. | Palm Springs, CA | $117.24M |
| JFK Memorial Hospital, INC. | Indio, CA | $61.66M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.